Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05377216 · ClinicalTrials.gov registry record · Early Phase 1
Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
A Early Phase 1 study of Ventricular Tachycardia, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05377216: Recruiting Early Phase 1 study of Ventricular Tachycardia, sponsored by University of Pennsylvania.
NCT05377216 is a Early Phase 1 study of Ventricular Tachycardia that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 20 participants, below the 288-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05377216, a Early Phase 1 study of Ventricular Tachycardia, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.
Primary Outcome
Change in Ventricular Effective Refractory Period at 600ms drive train (measured in milliseconds)
Conditions Studied
Interventions
- DRUG Stellate Ganglion Block
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2027-07-01 |
| Phase | Early Phase 1 |
What NCT05377216 shows while recruiting
NCT05377216 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 288-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Stellate Ganglion Block is the first listed.
NCT05377216 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05377216 about?
NCT05377216 is a clinical study titled "Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation". Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.
What is the current status of trial NCT05377216?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2022-09-01. Estimated completion is 2027-07-01.
What conditions does trial NCT05377216 study?
This clinical trial studies the following conditions: Ventricular Tachycardia.
What interventions are being tested in trial NCT05377216?
The interventions under investigation include: Stellate Ganglion Block (DRUG).
Who is sponsoring clinical trial NCT05377216?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05377216 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05377216's enrollment target sits among peer trials
20 26th of 28 higher than 2 of 28 other Ventricular Tachycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventricular Tachycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ventricular Tachycardia Mechanisms
RECRUITING · NA
-
Randomized Assessment of TcMS for VT Storm
RECRUITING · NA
-
Cardiac Radioablation for VT
RECRUITING · NA
-
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation
RECRUITING
-
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
RECRUITING · NA
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI